Facebook
Twitter
LinkedIn
ForwardCarol Chamberlain, PharmD, MA
Professional Experience | |
2003-Pres | Clinical Pharmacy Pain Specialist, Parkland Health & Hospital System |
2001-2003 | Clinical Inpatient Pharmacist, Parkland Hospital |
1997-2001 | Clinical Pharmacist, Baylor Hospital/Drug Emporium |
Licensure | |
1997 | Texas License #37367 |
Education | |
1997 | Abbott Northwestern Hospital – Pain Management Residency, Minneapolis, MN |
1996 | University of Minnesota College of Pharmacy – Doctor of Pharmacy, Minneapolis, MN |
1994 | University of Minnesota College of Pharmacy – Bachelor of Science, Minneapolis, MN Graduated Suma Cum Laude |
1990 | Masters Program – Educ Psych. University of Minnesota |
1984 | Gustavus Adolphus College – Bachelor of Arts in Psychology (Minors: Biology & Art) St. Peter, MN. Graduated Magna Cum Laude
|
Professional affiliations
2018- pres Academy of Integrative Pain management (AIPM)
2001- pres American Academy of Pain Medicine (AAPM)
2018-pres Practical Pain Management (PPM)
2001-pres American Society of Health-Systems Pharmacists (ASHP)
Honors & Awards 2014-2018 Biggest Heart Award | |
2017 2016 2014 | DFWHC Employee of the Year Nominee Patient Safety Champion -1st place educator Preceptor of the year |
1994 | Kappa Epsilon Award – Outstanding Leadership |
1994 | F.J. Wulling Award – Highest GPA |
1992-1993 | Melendy Scholarship |
1993 | F.J. Wulling Award – Highest GPA |
1992 | Rho Chi Award- first year student with highest GPA |
1992-1996 1990 | Dean’s list – GPA > 3.5 Employee Recognition Award – Outstanding Counseling (Adolescent Treatment Center) |
1984 Phi Beta Kappa
1980-1984 Dean’s list – GPA > 3.5
Committees | |
2018-pres | Opioid Stewardship Education |
2018-pres | Opioid Stewardship Clinical Practice |
2017-pres | Integrative Pain Clinic biweekly meetings |
2018-pres | Capnography Performance Improvement Project |
2011-pres 2011-2014 | Pain and Sedation Workgroup – facilitator Moderate Sedation Committee |
2001-pres 2015-pres 2017-pres 2016-pres 2016-pres 2005-pres 2005-pres 2014-2015
| Pain P&T Sub-Committee – Facilitator Ethics committee – pharmacy representative Pain TJC workgroup – co-lead Addictions/Substance Abuse Program Pharmacy Advisory Council Clinical Specialists and Managers (CSM) Resident Advisory Committee (RAC) Hydrocodone Rescheduling Workgroup - co-lead |
Projects
2018-pres Capnopraphy Performance Improvement Project
2017–pres Opioid Stewardship Program
2016-pres Multimodal order set revision for all surgeries to reduce opioid usage and reduce length of stay (ERAS – enhanced recovery after surgery)
2001-pres Pain Management Inpatient administrative Policy – creation and revision
2016-pres Chronic Opioid Policy for Providers – creation and revision
2015-pres Pasero Opioid-Induced Sedation Scale (POSS) policy and education
2007-pres Multiple proposals (seven) for a Multidisciplinary Pain Program
2014-pres Naloxone Guideline
2012-pres Methadone Guidelines and restrictions – revision 2017
2004-pres Pain Reference Card with revisions
2008-2017 Informed Consent/Controlled Substance Agreement - creation and revision
2001-2017 Pain P & T Monographs – Monovisc, Synvisc -1, Euflexxa, Exparel, IV APAP, Duloxetine, Lidocaine 5% patch, Diclofenac gel, Meloxicam, Intranasal Narcan for ambulatory use, Intranasal Narcan, fentanyl, midazolam with MAD device in the ED, Ketamine PO, Ketamine IV PCA, Fentanyl IV PCA, ON-Q pump (bupivacaine, ropivacaine), Epidural (all formulations – fent/bup, hydro/bup)
2017 Vizient Opioid ADE Collaborative (9 month) - House-wide project on all chronic pain patients taking opioids for at least 3 months. Ensure compliance with CDC and Texas Medical Board guidelines.
2017-pres Chronic Pain/Opioid registry in EPIC: collaborative effort with opioid stewardship team
2005-pres MUE’s – IV APAP, Hyaluronate products, liposomal bupivacaine, meperidine IV PCA, Ketamine PO for wound care (current), Naloxone/flumazenil ongoing since 2011
2011 to pres EPIC changes to ensure safe and effective pain management:
- Implemented administration instruction warnings to consider giving 1 hour apart on ALL CNS depressant PRN’s – 2011
- Changes to individual ERX’s to add lower dose buttons – opioids (e.g. morphine, benzodiazepines, haloperidol)
- Preprogrammed opioid naïve settings in all IV PCA orders – 6/2011
- Implemented BPA alert on pediatric dosing - 2011
- Opioid/disease warnings on all morphine products – 2011
- Revise order sets with pain medications - December 2011 to present
- Revise BPA on high risk patients receiving opioids - 2012
- POSS sedation scale built in EPIC for nursing documentation- April 23, 2012- “go live”
- Methadone restriction to specific consult services - Approved P & T April 5, 2012
- Establish criteria for IV PCA’s - June 7, 2012- P & T Review
- Lorazepam dosing recommendations for benzodiazepine naïve and older patients – May, 2013
- Procedural order set revisions for moderate sedation. June, 2013
- Revision to fentanyl patch panels
- Codeine restriction to patients greater than or equal to 13 years of age
2011 to pres PYXIS changes to ensure safe and effective pain management:
- Remove high concentration opioids from select pyxis machines (e.g. switch out hydromorphone 2mg/ml and replace with 1mg/ml, change morphine 10mg/ml, 5mg/ml to 4mg/ml, 2mg/ml, remove fentanyl 50mcg/ml 20ml and leave 2ml and 5ml)
- Add pyxis alert with onset, peak and duration for IV sedation medications (e.g. opioids, benzodiazepines etc)
- Pediatric alert for hydrocodone solution, making only one hydrocodone concentration available on EPIC preference list and in pyxis.
Presentations
2001 to pres Safe and Effective pain management every 3 months for med-surg nurses
2017 Vizient Adverse Drug Event Improvement Collaborative: Prescribing Opioids for Chronic Pain Knowledge Transfer Webinar
2017 TCPI Clinician Event, Specialty Care – Opioid Stewardship
2017-pres Opioid Stewardship – phase I : opioid epidemic, CDC, TMB guidelines and Parkland Policy
2017-pres Opioid stewardship – phase II : Baseline data from the chronic pain registry, urine tox screens, pain medication management
2017 The Role of Sub-dissociative Ketamine in Pain Management
2014-2017 Patient Controlled Analgesia (PCA) and Conversion to PO/TDF: Clinical Pearls
Internal Medicine and Palliative care residents and faculty
2008- pres Safe and Effective pain management for Surgery Interns
2008-pres Safe and Effective pain management for Internal Medicine interns/residents
2012-pres Developed Pain CIA training through Parkland Pathways – for providers and other clinical staff
2008-pres Pain Self-Management for Patients
2008-pres Non-opioids and Co-analgesics
1997-2004 It still Hurts
1997-2004 Pain Management Review
1997-2004 Adjuvant Pain Medications
1997-2004 Antidepressants in the management of Chronic Pain
Posters/Publications/Platforms |
Chamberlain C, Kandil E. Adverse Drug Event Improvement Collaborative: Prescribing Opioids for Chronic Pain Knowledge Transfer Webinar. Vizient Webinar Oct 2017
|
|
Kandil, E, Weinfeld M, Bender C, Minhajuddin A, Melikman E, Chamberlain C, Ogunnaike, B. Prescription Opioid Overdose, Narcan use in The Emergency Department Before and After Hydrocodone Rescheduling: Are We Making a Difference? American Society of Anesthesiologists Annual Fall Meeting Oct 2016.
|
Schultz S, Chamberlain C, Vulcan M, Rana H, Patel B, Alexander J. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center. Journal of Opioid Management May 2016; 12(2): 119-122.
Chamberlain C, Ogunnaike B, Doherty K, Gasanova I, Edwards C, Parker T. Salazar G, Foster E, Joshi G, Alvarez A, Fox P. Reducation in opioid and Benzodiazepine Induced Sedation Events by Utilizing a Multi-disciplinary Committee Approach. Poster presented at Annual Performance Improvement week at Parkland Health & Hospital System 2016
|
Alvarez KS, Rahman AP, Chamberlain C, Cooper T, Lockwood A, Berge C. Implementation of medication therapy management in a post computerized physician order entry era (Abstract #260). Pharmacotherapy. October 2010;30(10):438e.
C. Chamberlain. Meperidine IV PCA Utilization, Poster presented at Annual Performance Improvement week at Parkland Health & Hospital System 2004
Belgrade M, Chamberlain C, Kellar P, et al. Opioid management of chronic non-malignant pain: another 150 cases. Abstract and poster presented at the annual meeting of the Midwest Pain Society. Chicago: 1998 Apr
|
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:02/02/2024Date updated:03/25/2024
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.